| Drugs | The effect of coffee on the PK of drugs | Mechanism | References |
| Escitalopram oxalate | Decrease absorption | Insoluble complex formation | [11] | Iron and iron-containing drugs | Decrease absorption | Insoluble complex formation | [14] | Midazolam | Decrease absorption | Changing pH | [19] | Phenothiazines and butyrophenone | Decrease absorption | Changing pH | [20] | Aspirin and felodipine | Increase absorption | Changing pH, increase gastric emptying rate | [24, 32] | Halofantrine | Increase absorption | Changing pH | [12] | Ergotamine and levodopa | Increase absorption | Changing pH | [25] | Thyroxine (T4) | Decrease absorption | Sequestering | [6] | Vitamin D and calcium | Decrease absorption | Affecting sink condition | [14] | Glucose | Decrease absorption | Inhibition of the activity of glucose-6-phosphatase | [35, 36] | Memantine and donepezil | Decrease distribution | By enhancing the tightness of the blood-brain barrier | [52] | Levodopa | Increase distribution | By inhibiting a metabolizing enzyme at peripheral NS and CNS | [39] | Clozapine, amitriptyline, lithium, theophylline, warfarin, clomipramine, fluvoxamine, imipramine, haloperidol, olanzapine, lidocaine, mexiletine, propranolol, triamterene, verapamil, ropivacaine, melatonin, dextromethorphan, methotrexate, and pefloxacin | Inhibit metabolism | By saturating a metabolizing enzyme | [8, 19, 41ā43, 45, 53, 54] | Paracetamol | Enhancing metabolism | Induce the activity of cytochrome P-448 | [46] | Minerals (calcium, magnesium, sodium, and chloride), water-soluble vitamins (vit B), oxandrolone, and epioxandrolone | Increase excretion | Increasing volume of urine | [49, 51] |
|
|